— Know what they know.
Not Investment Advice

NEO NASDAQ

NeoGenomics, Inc.
1W: +1.6% 1M: -13.7% 3M: +24.6% YTD: +41.9% 1Y: +59.7% 3Y: +21.2% 5Y: -61.8%
$17.27
+0.58 (+3.48%)
After Hours: $17.15 (-0.12, -0.69%)
Weekly Expected Move ±8.8%
$14 $15 $17 $18 $20
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 39 · $2.2B mcap · 117M float · 2.26% daily turnover · Short 61% of daily vol
Credit Risk of going bust: higher than 52% of companies Debt: 17.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.31 (down 98%), NeoGenomics, Inc. would be worth roughly what it owes.
Total debt $448.4M against a stock market value of $2.17B.
Distance to default 4.94 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $192.5M (short-term plus half of long-term), stock volatility 53.3%; Altman Z'' 1.45. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$1.4B -17.0% ▼
5Y CAGR: +6.6%
Total Liabilities
$523M -28.9% ▼
5Y CAGR: +12.2%
Shareholders Equity
$837M -7.3% ▼
5Y CAGR: +3.8%
Cash & Investments
$160M -58.7% ▼
5Y CAGR: -11.6%
Total Debt
$472M -22.0% ▼
5Y CAGR: +16.7%
Net Debt
$313M +31.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$317M$263M$342M$367M$160M
Short-Term Investments$199M$175M$73M$20M$0
Cash & ST Investments$515M$438M$415M$387M$160M
Net Receivables$112M$120M$131M$151M$159M
Inventory$23M$24M$24M$27M$29M
Other Current Assets$18M$8M$8M$12M$29M
Total Current Assets$682M$605M$597M$596M$376M
Property, Plant & Equip.$212M$199M$184M$174M$163M
Goodwill & Intangibles$969M$931M$896M$862M$811M
Long-Term Investments$236K$31K$0$0$0
Other Non-Current Assets-$49M-$30M$5M$6M$9M
Total Non-Current Assets$1.2B$1.1B$1.1B$1.0B$984M
Total Assets$1.9B$1.7B$1.7B$1.6B$1.4B
— Liabilities —
Accounts Payable$18M$21M$20M$22M$23M
Short-Term Debt$1M$0$0$201M$5M
Deferred Revenue$5M$8M$2M$409K$0
Other Current Liabilities$17M$15M$53M$75M$60M
Total Current Liabilities$87M$90M$96M$301M$88M
Long-Term Debt$532M$535M$538M$340M$405M
Other Non-Current Liab.$13M$13M$13M$12M-$51M
Total Non-Current Liabilities$674M$652M$643M$434M$435M
Total Liabilities$762M$742M$740M$736M$523M
— Equity —
Common Stock$124K$127K$127K$128K$129K
Retained Earnings-$15M-$159M-$247M-$326M-$434M
Accumulated OCI-$638K-$4M-$2M-$206K$4K
Total Stockholders Equity$1.1B$998M$942M$902M$837M
Total Liabilities & Equity$1.9B$1.7B$1.7B$1.6B$1.4B
— Key Metrics —
Total Debt$613M$611M$612M$605M$472M
Net Debt$296M$348M$269M$238M$313M
Total Investments$199M$175M$73M$20M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms